TABLE 1

Summary statistics for AUC(0–24h) of endogenous biomarkers in periods of RIF and RSV administration and coadministration of RIF and RSV

Values for AUC(0–24h), area under plasma concentration-time curve from time 0 to 24 hours, are expressed as arithmetic means ± S.D. (n = 7–8). AUC(0–24h) ratios relative to the RSV period are geometric means (90% CI).

AnalyteRIF PeriodRSV PeriodCoadministration of RIF and RSV Period
AUC(0–24h)AUC(0–24h) Ratio 
(Versus RSV Period)AUC(0–24h)AUC(0–24h)AUC(0–24h) Ratio 
(Versus RSV Period)
μM*hGeometric Mean (90% CI)μM*hμM*hGeometric Mean (90% CI)
DCA3.8 ± 2.33.2 (0.94, 11)2.0 ± 1.92.5 ± 2.70.95 (0.57, 1.6)
CA3.9 ± 1.81.6 (1.3, 1.9)2.7 ± 1.23.4 ± 1.81.3 (0.97, 1.8)
CDCA3.7 ± 2.31.1 (0.61, 2.1)4.1 ± 3.65.0 ± 4.71.0 (0.58, 1.8)
GCA4.1 ± 2.12.3 (1.8, 2.8)2.0 ± 1.13.5 ± 3.01.7 (1.3, 2.1)
GDCA19.7 ± 5.27.4 (3.1, 17.4)3.7 ± 2.79.4 ± 8.11.9 (1.0, 3.7)
GCDCA136.7 ± 61.51.8 (1.5, 2.2)78.6 ± 40.1142.7 ± 114.71.6 (1.3, 2.0)
GUDCA8.8 ± 3.81.1 (0.61, 2.2)9.2 ± 8.623.7 ± 31.31.9 (0.81, 4.6)
LCA1.6 ± 0.360.90 (0.78, 1.0)1.8 ± 0.331.5 ± 0.350.86 (0.75, 0.99)
TCA3.7 ± 4.02.0 (1.6, 2.6)2.2 ± 2.74.3 ± 4.22.2 (1.5, 3.2)
TDCA1.8 ± 0.794.8 (2.4, 9.6)0.58 ± 0.691.3 ± 1.32.1 (1.3, 3.4)
TCDCA11.0 ± 7.91.8 (1.6, 2.1)6.4 ± 4.313.4 ± 9.02.0 (1.5, 2.7)
THDCA/TUDCA0.38 ± 0.191.4 (0.82, 2.4)0.33 ± 0.260.45 ± 0.262.1 (1.6, 2.8)
UDCA/HDCA0.56 ± 0.300.66 (0.31, 1.4)1.2 ± 1.20.56 ± 0.340.97 (0.66, 1.4)
DHEAS92.3 ± 48.20.97 (0.89, 1.1)101.5 ± 45.597.1 ± 44.41.0 (0.95, 1.1)
HDA1.9 ± 0.822.2 (1.8, 2.6)0.90 ± 0.372.2 ± 0.532.5 (2.1, 3.0)
TDA1.3 ± 0.512.8 (2.2, 3.5)0.47 ± 0.261.5 ± 0.493.2 (2.4, 4.2)
CP Ia0.084 ± 0.0194.0 (3.7, 4.5)0.021 ± 0.0050.084 ± 0.0164.0 (3.7, 4.3)
CP IIIa0.013 ± 0.0043.4 (2.9, 4.1)0.004 ± 0.0010.013 ± 0.0033.5 (3.0, 4.0)
RSVa0.08 ± 0.030.37 ± 0.124.8 (4.0, 5.7)
  • CI, confidence interval.

  • a Data on plasma CP I, CP III, and RSV concentrations in healthy subjects are from a previous publication (Lai et al., 2016).